Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Bittner

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
JAMA|July 2, 2002
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)Deborah Grady, David Herrington, Vera Bittner, et al.
Journal of the American College of Cardiology|November 3, 2022
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of AlirocumabGregory G Schwartz, Michael Szarek, Andreas Zeiher, et al.
Journal of Lipid Research|September 13, 2019
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adultsMatthew T Mefford, Santica M Marcovina, Vera Bittner, et al.
The American Journal of Cardiology|August 9, 2014
Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary eventPaul Muntner, Huifeng Yun, Pradeep Sharma, et al.
Circulation|February 14, 2018
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart AssociationLaxmi S Mehta, Karol E Watson, Ana Barac, et al.
Progress in Cardiovascular Diseases|August 29, 2022
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination SurveyKartik Gupta, Tanya S Kakar, Vardhmaan Jain, et al.
Advances in Therapy|May 1, 2024
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World SettingsPaul Muntner, Lama Ghazi, Jenna Jones, et al.
European Heart Journal|May 25, 2006
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) studyB Delia Johnson, Leslee J Shaw, Carl J Pepine, et al.
ESC Heart Failure|September 27, 2016
Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccinationMomanna B Ahmed, Kanan Patel, Gregg C Fonarow, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2006
Phytoestrogens and lipoproteins in womenC Noel Bairey Merz, B Delia Johnson, Glenn D Braunstein, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
JAMA|July 2, 2002
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)Deborah Grady, David Herrington, Vera Bittner, et al.
Journal of the American College of Cardiology|November 3, 2022
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of AlirocumabGregory G Schwartz, Michael Szarek, Andreas Zeiher, et al.
Journal of Lipid Research|September 13, 2019
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adultsMatthew T Mefford, Santica M Marcovina, Vera Bittner, et al.
The American Journal of Cardiology|August 9, 2014
Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary eventPaul Muntner, Huifeng Yun, Pradeep Sharma, et al.
Circulation|February 14, 2018
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart AssociationLaxmi S Mehta, Karol E Watson, Ana Barac, et al.
Progress in Cardiovascular Diseases|August 29, 2022
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination SurveyKartik Gupta, Tanya S Kakar, Vardhmaan Jain, et al.
Advances in Therapy|May 1, 2024
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World SettingsPaul Muntner, Lama Ghazi, Jenna Jones, et al.
European Heart Journal|May 25, 2006
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) studyB Delia Johnson, Leslee J Shaw, Carl J Pepine, et al.
ESC Heart Failure|September 27, 2016
Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccinationMomanna B Ahmed, Kanan Patel, Gregg C Fonarow, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2006
Phytoestrogens and lipoproteins in womenC Noel Bairey Merz, B Delia Johnson, Glenn D Braunstein, et al.
Pageof 27